|
|
| |
|
Memorandum
of Understanding |
|
|
|
|
|
Made on the sixteenth day of September 2003 by and among
|
|
|
-
National AIDS Control
Organization, Ministry of Health and Family Welfare, an agency
of Govt. of India, with an address of 36, Janpath (Chandralok
Building), New Delhi-110001.
-
National
Council of Applied Economic Research, Parisila Bhawan, 11
Indraprastha Estate, New Delhi-110002.
-
Indian
Council of Medical Research (ICMR) with an address of Post Box
No. 4911, Ansari Nagar, New Delhi-110029,
-
The Institute of Health Systems
(IHS), HACA Bhavan, Opp.
Public Gardens, Hyderabad, AP 500004, and
-
United Nations Development Programm
(UNDP), 55, Lodi Estate,
New Delhi- 110 003.
|
|
|
| Article 1 |
The Joint United Nations Programme
on HIV/AIDS (UNAIDS) estimates that globally almost 40 million
adults and children are living with HIV/AIDS (December 2003).
Despite advances in the prevention and control strategies with
respect to HIV/AIDS, it is estimated that 1500 new infections
of HIV occur each day. Over the next few years, it is
anticipates that Asia will face the highest burden of new HIV
infections, India being particularly vulnerable. HIV/AIDS is
known to adversely impact development, but more research is
needed, also in India, to identify and quantify the exact
impact of HIV.
|
| Article 2 |
National AIDS Control Organization
(NACO), Ministry of Health & Family Welfare, Government of
India needs reliable estimates of both the burden of disease
and the socioeconomic impact of HIV/AIDS within the country.
Such information would be helpful in formulating future
strategies for reduction and mitigation of the impact of
HIV/AIDS epidemic. In collaboration with UNDP, ICMR, NCAER and
IHS, NACO seeks to initiate and implement these studies.
|
|
-
The UNDP is committed to promoting sustainable human
development and has vast experience in preparation of
Human Development Reports globally, nationally and at the
state levels also building on its strong networks as well
as the civil society. The Human Development Resource
Centre (HDRC), at the UNDP country office has a strong
commitment to mainstreaming HIV/AIDS as a development
issue.
-
The Indian Council of Medical Research (ICMR), New Delhi
is an apex body that provides stewardship and supports
biomedical research in India, is an autonomous body funded
by Ministry of Health & Family Welfare. It has a
network of 26 institutes and nearly 100 field stations
across the country. While several of institutes are
engaged in HIV/AIDS related research, its National AIDS
Research Institute (NARI) at Pun, spearheads research on
HIV/AIDS within the country. NARI brings together a
multidisciplinary team of scientists spanning the basic
sciences, applied and operations research and behavioral
science. ICMR's National Institute of Epidemiology (NIE),
Chennai provides consultancy in epidemiology, and design
of vaccine efficacy and clinical studies. Other major
institutes of ICMR involved HIV/AIDS research includes the
Tuberculosis Research Centre (TRC), Chennai (HIV/TB
co-infection), National Institute of Cholera and Enteric
Disease, Kolkata (opportunistic infections ofd Gut in the
HIV infected, Injecting Drug Users (IDUs) and HIV), and
provides support to ICMR activities on HIV/AIDS in the
North- East states. Trough its institutes the ICMR would
help in development of study protocol and take up studies
related to burden of disease in Maharastra, Tamil Nadu and
States of Northeast.
-
The National Council for Applied Economic Research (NCAER),
New Delhi is an autonomous apex body with vast expertise
in undertaking large scale macro economic research
studies. In this collaboration NCAER will conduct the
appropriate socioeconomic impact studies related to
HIV/AIDS epidemic.
-
The Institute of Health Systems (IHS), Hyderabad is an
autonomous research and training institution, sponsored by
Government of India programmes of the Department of Family
Welfare, Ministry of Health and Family Welfare. The IHS
specializes in Burden of Disease Estimation and related
research methodologies and serves as a base for an
extensive array of burden of disease study and training
initiatives in the country. The Andhra Pradesh Burden of
Disease study of IHS has been noted as a rigorous study of
state level burden of disease and is one of the first
national burden of disease studies in the world. Reliable
estimates of disease burden facilitate agenda setting and
readjustment of priorities within the health sector and
also within related sector like nutrition, drinking water
etc. In this collaboration, the IHS will conduct research
in estimating burden of disease in respect of HIV/AIDS, by
involving in all the stages of the study.
|
| Article 3 |
The above parties will fully
cooperate in accordance with the terms of this Memorandum of
Understanding and hereby aggress to participate in conducting
studies and respect of the burden of disease and the
socioeconomic impact of HIV/AIDS in high prevalence states as
per the roles and objectives outlined in this memorandum
|
| Article 4 |
Scope of the Work |
| Article 4.1 |
Burden of Disease:- ICMR and
IHS will develop and finalize the design of a study protocol
on disease burden in the known six high prevalence States 1 on
the basis of available data and will undertake such additional
studies as essential to estimate the burden of disease. This
would include, inter-alia
|
|
-
Analysis of Surveillance Data: The current data
collection systems will be analyzed and evaluated for
consistency of data elements, completeness and accuracy.
- Estimation of incidence of HIV/AIDS: A close study of
the epidemiological profile will facilitate systematic
estimation of the incidence of HIV/AIDS district-wise,
group-wise, gender-wise, rural/urban, age group and
vulnerability ti HIV/AIDS by using "Dismod", a
software used for internal validation of estimated
incidence of disease from prevalence data, in the selected
states and provide future scenarios.
- Estimation of morbidity and mortality on account of
HIV/AIDS in the select states including future scenarios
(Estimation of Burden of Disease on account of HIV/AIDS in
the study areas).
- All of the above research will provide inputs into the
socioeconomic impact studies undertaken by NCEAR, ICMR
& IHS will also provide technical assistance in
interpreting of prevalence and burden of disease.
- The study design to be developed by ICMR and IHS will
clearly identify specific technical and geographical
responsibilities (ICMR- Tamil Nadu, Maharashtra, Manipur
and Nagaland; IHS- Andhra Pradesh and Karnataka) between
the two implementing agencies and the level of support
that each will provide to NCEAR. The Steering Committee
(See article 10) will facilitate smooth functioning of the
partnership and also enable sharing information. Assist in
mobilizing additional technical assistance and manage peer
review , where appropriate , of the design and findings.
|
| Article 4.2 |
Socioeconomic Impact:- The impact
studies will be undertaken by NCEAR in all six states; viz
Maharashtra, Karnataka, Andhra Pradesh, Tamil Nadu, Manipur
and Nagaland. NCAER will use the prevalence and incidence
rates and other relevant estimates computed by ICMR and IHS
undertaking socioeconomic studies. More specifically the NCEAR
will focus its research on the following:
|
|
-
Analyze the nature and type of the economic impact of
HIV/AIDS on households: This segment of research will help
to find out state specific strategies that are needed to
alleviate the problems faced by HIV/AIDS affected
households. The focus will be investigate the relationship
between HIV/AIDS and distribution on income and wealth,
changes in structure of employment and social security.
-
Assess sectoral impact: State Specific measurement of
the current and potential impact of HIV/AIDS on different
sectors of the economy including (but not limited to)
agriculture, tourism and health care industry will be
undertaken.
-
Assess net impact of HIV/AIDS on the State and national
level economic performance: An integrated model
incorporating specific sectors, associated labour force
participation and effects on productivity will be
developed to evaluate and estimate the impact of HIV/AIDS
on the respective state Net State Domestic Product (NSDP).
|
| Article 5 |
Responsibilities of each agencies: |
|
- Burden of Diseases: Institutes of ICMR and IHS
- Socioeconomic Impact : NCAER
- Providing available information/material and state level
facilitation and cooperation of state level authorities:
NACO
- Financial and Technical Resources (as per Article 10.4):
UNDP
|
| Article 6 |
Research Ethics: The participating
agencies here by agree to follow the general research ethics
guidelines as laid down by ICMR for carrying out biomedical
research in human subjects and other relevant institutional
guidelines. It is the responsibility of the implementing
agencies to get required clearances through their appropriate
ethical committees or institutional review boards as required
for carrying out biomedical research in human subjects.
|
| Article 7 |
NACO through Ministry of Health and
Family Welfare would facilitate, in accordance with the
existing rules and regulations and guidelines, the granting of
appropriate terms and permissions to work on this initiative
in a transparent manner and will facilitate and coordinate
functioning amongst the participating agencies.
|
|
Article 8 |
The agencies undertaking the study will
be responsible for the management of the study component agreed
upon and will be responsible for the conduct of their
investigators. NACO is indemnified from the effects of the action
of the agencies or their representatives in the field and NACO
will not be held responsible for legal issues arising out of the
same.
|
| Article 9 |
Publication: Participating
institutions will have limited publications in respect of work
done by them, and subject to approval in writing from NACO.
The agencies desirous of publishing their work will write to
the Project Director , NACO for approval and if NACO does not
respond with in 45 days from the receipt of the request, it
shall be deemed as approved.
|
| Article 10 |
Management and Institutional
Arrangement. |
| Article10.1 |
Upon signing of the agreement , NACO
will constitute a Steering committee with the following
members- NACO, ICMR, NCAER, IHS, UNDP, UNAIDS, three SACS
representatives and one PLHA representative with the
Additional Secretary (H) and Project Director NACO as Chair.
The Steering Committee will meet on a quarterly basis and the
implementing agencies will represent progress reports at these
meetings. The Steering Committee will also responsible for
overall monitoring of the study, facilitation of smooth
functioning between the partners, facilitate timely flow of
technical and financial resources and will undertake advocacy
and appropriate dissemination of the study findings.
|
| Article10.2 |
The Steering Committee may set up a
technical monitoring group with specific terms of reference
for regular monitoring of the progress of the study.
|
| Article10.3 |
NACO will be responsible for
obtaining the necessary clearances and for providing available
information from the national and state level
organization/institutions on the epidemic. NACO will also
facilitate engagement and activate cooperation of the state
level authorities in the conduct of the study. NACO will also
facilitate (through IHS) a two day meeting of experts to
further detail the methodology of the study with in 15 days of
the signing of MOU, and this methodology will bind the
partners, until such time as they are further adjusted the
Steering Committee as per Article 10.1
|
| Article10.4 |
Each of the implementing agencies
will be provided with a block start-up grant as per budget
given by the resource institutes (Annexure -I) with in seven
days of signing of MOU. Based on the study protocol developed
and approved by the Steering Committee, UNDP release
additional installments for the completion of the study, as
per request of the Chair of the Steering Committee. UNDP will
also facilitate peer review of the study findings and
recommendations and also engage ( within the availability of
the budget- Annex 1), any additional technical expert that may
be required in the effective conduct of the study.
|
| Article10.5 |
ICMR , NCAER and IHS will ensure
that the study is conducted maintaining highest quality
standards. The total duration of the study including final
reports will be 12 months from the signing the MOU. A work
plan is attached as Annexure-II.
|
|
|
|
|
|
|
IN WITNESS WHEREOF THE DULY AUTHORIZED SIGNATORIES OF the parties
have singed this Memorandum of Understanding on the day and year
first above written.
|
|
|
Dr Meenakashi Datta Ghosh Addl. Secretary and
Project Director National AIDS Control Organization |
Dr. N.K Gangully Director General Indian Council of Medical Research |
| |
Mr. Suman K. Bery Director General National Council of Applied Economic Research |
Dr. C.K George Director Institute of Health System |
| |
Dr. Maxine Olson UNDP Resident Representative and UN Resident Coordinator in
India |
|
|
|
|
|
|
Annexure -I: Budget
|
|
|
| Sl.No |
Name of the Agency |
Total Budget |
Strat-Up Grant |
| 1. |
Institute of Health System (IHS) Hyderabad,
Andhra Pradesh |
47.55* |
35 |
| 2. |
National Council of Applied Economic Research
(NCAER), New Delhi |
72.54 |
43.52 |
| 3. |
Indian Council of Medical Research (ICMR), New
Delhi |
79 |
16 |
| |
Total |
199.09** |
94.52 |
|
|
|
* Provisional estimates for a duration of six months. Total amount
will be revised after study design is finalized.
** Estimate for total project period will be revised after
study design is finalized.
| |
| | |
|
Annexure -II :
Time line | |
|
| Activities |
Outputs |
Time frame |
- Review the existing literature in the
field especially as it applies to India
|
Document the
literature search |
2 months from
commencement of contract |
- Develop a study protocol by
which impact of the HIV/AIDS epidemic on the
sectors and areas outlined above can be
studied
|
Study protocol in
place |
months from the
commencement of the contract |
- Collect data and estimate the
results of the study
|
Report of the study |
9 months from the commencement of
the contract. |
- Analyze the national response to
the epidemic in the light of the study
findings and recommend changes in strategy,
if any
|
Report of the
analysis and recommendations. |
10 months from the
beginning of the study. |
- Dissemination of the findings of the
workshop.
|
Workshop report. |
11 months from the
commencement. |
- Finalization of report
|
Final study report. |
12 months from the
study. |
| |
| | |
|
|
|
|
|
|